Medication Review, Inc. — Form D
Medication Review, Inc. of SPOKANE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2012-03-22. The offering totals $2.5M, of which $12K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2012-03-22
- Form: D
- Accession: 0001497310-12-000001
- Industry: Pharmaceuticals
- Exemptions: 06, 46
- Total offering: $2.5M
- Amount sold: $12K
- Remaining: $2.5M
- Minimum investment: $10K
- Investors: 1
- Date of first sale: 2012-03-19
- Security types: equity
- Revenue range: $1,000,001 - $5,000,000
- SEC file number: 021-175395
Issuer
- Name: Medication Review, Inc.
- CIK: 0001497310
- Entity type: Corporation
- Jurisdiction: WASHINGTON
- Incorporated: 2005
- Address: 104 S. FREYA, SPOKANE, WA, 99202
- Phone: 509-343-5200
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| K. Douglas Crafton | Director | Spokane, WA |
| Linda F Garrelts-MacLean, BPharm, RPh | Director | Spokane, WA |
| Mary R Giannini | Director | Spokane, WA |
| Tom R Jensen, MPA | Director | Spokane, WA |
| James F Karel, MS | Director | Spokane, WA |
| Michael R Anderegg | Executive Officer | Spokane, WA |
| K. Douglas Crafton | Executive Officer | Spokane, WA |
| Kyle R Downey, PharmD | Executive Officer | Spokane, WA |
| Christopher R Terriff, RPh | Executive Officer | Spokane, WA |
| Adam R Gelhausen | Executive Officer | Spokane, WA |
| Dennis R Hake | Executive Officer | Spokane, WA |
| Chris R Terriff, RPh | Executive Officer | Spokane, WA |
Other filings by this issuer (1)
More